Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Cytokinetics (CYTK) Receivables - Net (2016 - 2025)

Cytokinetics (CYTK) has disclosed Receivables - Net for 10 consecutive years, with $17.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Net changed N/A to $17.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.8 million, a N/A change, with the full-year FY2025 number at $17.8 million, changed N/A from a year prior.
  • Receivables - Net was $17.8 million for Q4 2025 at Cytokinetics, up from $1.8 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $51.8 million in Q4 2021 to a low of $147000.0 in Q4 2022.
  • A 5-year average of $5.9 million and a median of $2.0 million in 2022 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: surged 1072.38% in 2021, then tumbled 99.72% in 2022.
  • Cytokinetics' Receivables - Net stood at $51.8 million in 2021, then crashed by 99.72% to $147000.0 in 2022, then surged by 772.79% to $1.3 million in 2023, then crashed by 80.98% to $244000.0 in 2024, then surged by 7180.33% to $17.8 million in 2025.
  • Per Business Quant, the three most recent readings for CYTK's Receivables - Net are $17.8 million (Q4 2025), $1.8 million (Q3 2025), and $8.4 million (Q2 2025).